Nadine McGrath

1 week ago | stockhead.com.au | Nadine McGrath

ASX heath sector falls 1.1% over past five daysThe US FDA approves CSL’s Andembry to prevent attacks of hereditary angioedemaClever Culture systems records its second consecutive quarter of positive cashflow operationsHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock pick.

1 week ago | theaustralian.com.au | Nadine McGrath

Vital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist Nadine McGrath. In this episode Nadine chats to John McCutcheon, the President and CEO of EBR Systems (ASX:EBR). EBR is focused on its lead technology, the WiSE CRT System, an innovative device designed to overcome the limitations of conventional Cardiac Resynchronisation Therapy (CRT) and is the only leadless left ventricular endocardial pacing (LVEP) device on the market.

2 weeks ago | stockhead.com.au | Nadine McGrath

ASX heath sector falls 1.1% over past five days, while broader markets flat as Middle East tensions flareCochlear downgrades full-year profit expectations but launches a world first Monash IVF head Michael Knaap resigns after another embryo mix-up Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock pick.

3 weeks ago | stockhead.com.au | Nadine McGrath

ASX health stocks dipped 0.82% over the past five days while the broader market has risen 1.26%EMVision appoints Ramsay Health Care CEO to board and expands sites of pivotal trialFirst Japan site opens for Dimerix’s phase III clinical trial of DMX-200 in rare kidney diseaseHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock pick.

3 weeks ago | stockhead.com.au | Nadine McGrath

FightMND will hold its Big Freeze fundraiser for motor neurone disease on June 9Neurizon working to develop a potentially effective treatment for common form of motor neurone diseaseRecent data shows Neurizon’s NUZ-001 drug well-tolerated and may extend life in ALS/MND patientsEver been in an ice bath? It’s cold…really, really cold. On June 9 celebrities will plunge into icy waters in front of the MCG crowd as the Melbourne Demons take on Collingwood for this year’s Big Freeze.